MicroRNA-155 inhibits angiotensin II-induced vascular smooth muscle cell proliferation

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 15, Issue 2, 2014, Pages 109-116

  Yang, Li Xia ^a   Liu, Gao ^a   Zhu, Guo Fu ^a   Liu, Hong ^a   Guo, Rui Wei ^a   Qi, Feng ^a   Zou, Ji Hong ^a  

^a KUNMING GENERAL HOSPITAL   (China)

Author keywords

angiotensin II; angiotensin II 1 type receptor; MicroRNA 155; proliferation; vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN II; CHOLECYSTOKININ OCTAPEPTIDE; EDOXUDINE; MICRORNA 155; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; MICRORNA; MIRN155 MICRORNA, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; ATR1 GENE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL COUNT; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; FEMALE; METABOLISM; PREGNANCY; PRIMARY CELL CULTURE;

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; CELL COUNT; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MICE; MICE, INBRED C57BL; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; PREGNANCY; PRIMARY CELL CULTURE; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 84902164842     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320313503693     Document Type: Article

References (30)

1. Raines EW. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: Relationship to vascular disease. Int J Exp Path. 2000 ; 81: 173-182
2. Sanada F, Taniyama Y, Iekushi K, et al. Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells. Circ Res. 2009 ; 105: 667-675
3. Miyazaki M, Takai S. Involvement of angiotensin II in development of atherosclerosis [in Japanese]. Nihon Rinsho. 2002 ; 60: 1904-1910
4. Gross CM, Gerbaulet S, Quensel C, et al. Angiotensin II type 1 receptor expression in human coronary arteries with variable degrees of atherosclerosis. Basic Res Cardiol. 2002 ; 97: 327-333
5. Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009 ; 460: 705-710
6. Zhu N, Zhang D, Chen S, et al. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis. 2011 ; 215: 286-293
7. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: Lessons from mouse models. Nat Rev Immunol. 2008 ; 8: 802-815
8. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol. 2009 ; 54: 2129-2138
9. Liuzzo G. Atherosclerosis: An inflammatory disease. Rays. 2001 ; 26: 221-230
10. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011 ; 12: 204-212
11. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 2008 ; 28: 812-819
12. Oishi Y, Manabe I, Imai Y, et al. Regulatory polymorphism in transcription factor KLF5 at the MEF2 element alters the response to angiotensin II and is associated with human hypertension. FASEB J. 2010 ; 24: 1780-1788
13. Sanada F, Taniyama Y, Iekushi K, et al. Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells. Circ Res. 2009 ; 105: 667-675
14. Diep QN, Li JS, Schiffrin EL. In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels. Hypertension. 1999 ; 34: 617-624
15. Yang LX, Ye JS, Guo RW, et al. The effect of the expression of angiotensin II on extracellular matrix metalloproteinase inducer (EMMPRIN) in macrophages is mediated via the AT1/COX-2/PGE2 pathway. Inflamm Res. 2010 ; 59: 1033-1040
16. Yusuf S, Sleiht P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000 ; 342: 145-153
17. Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet. 2002 ; 359: 995-1003
18. Fox K. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, doubled-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003 ; 362: 782-787
19. Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010 ; 107: 677-684
20. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004 ; 116: 281-297
21. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer. 2007 ; 96: R40 - R44
22. Liu X, Cheng Y, Zhang S, et al. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res. 2009 ; 104: 476-487
23. Santovito D, Mandolini C, Marcantonio P, et al. Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert Opin Ther Targets. 2013 ; 17: 217-223
24. Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009 ; 460: 705-711
25. Yu ML, Wang JF, Wang GK, et al. Vascular smooth muscle cell proliferation is influenced by let-7d microRNA and its interaction with KRAS. Circ J. 2011 ; 75: 703-709
26. Sun SG, Zheng B, Han M, et al. miR-146a and Krüppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep. 2011 ; 12: 56-62
27. Faraoni I, Antonetti FR, Cardone J, et al. miR-155 gene: A typical multifunctional microRNA. Biochim Biophys Acta. 2009 ; 1792: 497-505
28. Dai Y, Qiu Z, Diao Z, et al. MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/SVneo cells via down-regulating cyclin D1. Placenta. 2012 ; 33: 824-829
29. Lu C, Huang X, Zhang X, et al. miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood. 2011 ; 117: 4293-4303
30. Zhu N, Zhang D, Chen S, et al. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis. 2011 ; 215: 286-293